Valuation: GRAIL, Inc.

Market Cap 3.39B 2.94B 2.78B 2.51B 4.72B 325B 4.75B 33.13B 12.75B 165B 12.73B 12.45B 526B P/E 2026 *
-7.56x
P/E 2027 * -7.13x
Enterprise Value 2.78B 2.41B 2.28B 2.06B 3.87B 267B 3.9B 27.18B 10.46B 135B 10.44B 10.21B 431B EV / Sales 2026 *
15.4x
EV / Sales 2027 * 13.5x
Free-Float
95%
Yield 2026 *
-
Yield 2027 * -
1 day+0.48%
1 week-4.06%
Current month-4.38%
1 month+11.82%
3 months+26.89%
6 months+76.24%
Current year-11.33%
1 week 73.46
Extreme 73.46
79.19
1 month 66.99
Extreme 66.99
85.49
Current year 41.5
Extreme 41.5
118.84
1 year 36.98
Extreme 36.98
118.84
3 years 12.33
Extreme 12.33
118.84
5 years 12.33
Extreme 12.33
118.84
10 years 12.33
Extreme 12.33
118.84
Manager TitleAgeSince
Chief Executive Officer 62 2026-05-31
Director of Finance/CFO 47 2021-10-31
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 62 2026-03-11
Director/Board Member 58 2024-06-20
Director/Board Member 66 2024-06-20
Date Insider Type Main position Quantity % Market Cap. Importance
8/27/26 Sell

Chief Executive Officer

-5,000 0.0117%
8/27/26 Sell

Chief Financial Officer

-7,900 0.0184%
7/15/26 Free

Director

276 0.0006%
Change 5-day change 1-year change 3-year change Capi.($)
+0.48%-4.06%+92.96% - 3.39B
-0.26%-0.26%-2.22%+26.47% 45.81B
-0.12%-1.19%+343.42%+545.03% 43.91B
+1.51%+4.04%+45.01%+27.38% 44.39B
-2.07%-1.42%+4.28%+72.97% 39.4B
-0.73%-3.06%+9.63%+38.92% 31.26B
-9.49%-11.23% - - 15.75B
+4.21%+5.01%+24.99%+121.62% 17.32B
+0.73%+4.34%+18.17%+34.53% 14.73B
-0.08%-2.81%+79.24%+31.27% 13.03B
Average -0.58%-1.49%+68.39%+112.27% 26.9B
Weighted average by Cap. -0.45%-1.27%+76.98%+133.98%

Financials

2026 *2027 *
Net sales 181M 157M 148M 134M 252M 17.36B 254M 1.77B 680M 8.8B 680M 665M 28.07B 227M 196M 186M 168M 316M 21.75B 318M 2.22B 853M 11.03B 852M 833M 35.17B
Net income -428M -371M -351M -318M -596M -41.09B -601M -4.19B -1.61B -20.83B -1.61B -1.57B -66.44B -467M -405M -383M -347M -651M -44.84B -655M -4.57B -1.76B -22.74B -1.76B -1.72B -72.51B
Net Debt -609M -528M -499M -452M -848M -58.43B -854M -5.95B -2.29B -29.63B -2.29B -2.24B -94.49B -331M -287M -271M -246M -461M -31.77B -464M -3.24B -1.25B -16.11B -1.24B -1.22B -51.38B
Logo GRAIL, Inc.
Grail, Inc. is a healthcare company focused on saving lives and shifting the paradigm in early cancer detection. The Company is focused on alleviating the global burden of cancer by using sequencing, population-scale clinical studies, and machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. Its targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. Its multi-cancer early detection test, the Galleri test, is a commercially available screening test for early detection of multiple types of cancer. The Galleri test can be used to screen for cancer before a person becomes symptomatic, when cancer may be more easily treated and potentially curable. The Galleri test can indicate the origin of the cancer.
Employees
910
Date Price Change Volume
26-09-15 US$75.89 +0.48% 1,514,687
26-09-14 US$75.53 -0.92% 1,145,791
26-09-11 US$76.23 -1.71% 360,985
26-09-10 US$77.56 +0.10% 897,064
26-09-09 US$77.48 -2.05% 591,087
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
75.89USD
Average target price
77.00USD
Spread / Average Target
+1.46%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. GRAL Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!